BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Structure-based design of antipsychotic without motor side effects

By Biocentury staff
February 11, 2022 8:56 PM UTC

DISEASE CATEGORY: Neurology

INDICATION: Psychosis; depression...

BCIQ Company Profiles

ShanghaiTech University

BCIQ Target Profiles

Dopamine D2 receptor (DRD2)

Dopamine D3 receptor (DRD3)

Serotonin (5-HT1A) receptor

BCIQ Company Profiles

ShanghaiTech University

BCIQ Target Profiles

Dopamine D2 receptor (DRD2)

Dopamine D3 receptor (DRD3)

Serotonin (5-HT1A) receptor

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS